News We’re Watching: SALSA Reintroduced, FDA Approves Abbott Valve, Metallic Implant Study
Executive Summary
A bill aimed at preventing laboratory reimbursement cuts has been reintroduced in the US Congress. Additionally, an Abbott valve landed FDA approval, On Target Labs reported trial results, and the FDA warned that dental palate expanders may pose health risks to adults.
You may also be interested in...
FDA Advisory Panel Agrees Pulse Oximeter Skin Pigment Discrepancies Pose Clinical Threat
The FDA’s Anesthesiology and Respiratory Therapy Devices advisory panel met to discuss racial and skin-pigmentation bias in pulse oximeter devices as well as recommendations for the agency.
Clinical Labs Group Wins Appeal In Medicare Payment Case
The trade group is suing to get HHS to revise its method for setting laboratory payments to better reflect higher fees paid by hospital-based facilities. The case now goes back to district court.
Minute Insight: FDA Approves First Fluorescent Imaging Agent For Ovarian Cancer
On Target Laboratories’ Cytalux (pafolacianine) is now approved for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions.